PTEN and metastatic malignant neoplasm: Modulation of the expression of oncogenes and tumor suppressor genes including the Bcl-2 family, caspase enzymes, phosphatase and tensin homolog (PTEN), and p53 are beneficial markers for monitoring, diagnosis, and targeted treatment of metastatic cancer (10, 11).